Crossmark

Discontinuation and switching of postpartum contraceptive methods over twelve months in Burkina Faso and the Democratic Republic of the Congo: a secondary analysis of the Yam Daabo trial

Crossref DOI link: https://doi.org/10.1186/s40834-020-00137-2

Published Online: 2020-11-23

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Coulibaly, Abou http://orcid.org/0000-0001-6015-3824
Millogo, Tieba

Baguiya, Adama

Tran, Nguyen Toan

Yodi, Rachel

Seuc, Armando

Cuzin-Kihl, Asa

Thieba, Blandine

Landoulsi, Sihem

Kiarie, James

Mashinda Kulimba, Désiré

Kouanda, Séni
Funding

Funding for this research was provided by:

Goverment of France
License Information

Text and Data Mining valid from 2020-11-23

Version of Record valid from 2020-11-23
More Information

Article History

Received: 21 August 2020

Accepted: 10 November 2020

First Online: 23 November 2020

Ethics approval and consent to participate

: The WHO Research Ethics Review Committee approved the trial, as well as the ethics committee for health research in Burkina Faso and the School of Public Health ethics committee in DR Congo. Moreover, the trial was registered in the Pan African Clinical Trials Registry (PACTR201609001784334).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below